This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a McGill University directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $75,000
Maternal pre-eclampsia and respiratory syncytial virus disease in infant
CIHR · 2024 · Principal investigator
- $275,400
The test-negative design for the estimation of COVID-19 vaccine effectiveness: design evaluation and development of statistical methods in the evolving context
CIHR · 2022 · Co-investigator
Maternal pre-eclampsia and respiratory syncytial virus disease in infant
Principal investigators: Ukah, Ugochinyere Viv; Auger, Nathalie; Merckx, Joanna-Trees
Keywords: Hypertensive Disorders Of Pregnancy; Pediatrics; Preeclampsia; Respiratory Syncytial Virus
The test-negative design for the estimation of COVID-19 vaccine effectiveness: design evaluation and development of statistical methods in the evolving context
Principal investigators: Schnitzer, Mireille E; Talbot, Denis
Keywords: Biostatistical Methods; Case-Control; Causal Inference; Propensity Score; Simulation Study; Test-Negative Design
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.